Pomerantz Appointed Co-Lead Counsel in CorMedix Securities Litigation

On October 12, 2021, U.S. District Judge Julien Xavier Neals of the District of New Jersey appointed Pomerantz LLP as Co-Lead Counsel on behalf of John V. Levon, the Lead Plaintiff in In re CorMedix Inc. Securities Litigation, 20-cv-13819 (D.N.J.), a securities action brought on behalf of a class of defrauded investors concerning alleged material misrepresentations related CorMedix Inc.’s manufacturing process of its lead product candidate for the treatment of catheter-related bloodstream infections (“CRBSIs”). CorMedix is a biopharmaceutical company that focuses on developing and commercializing therapeutic…